P-Phenetidine (CAS 156-43-4): A Key Intermediate for Pharmaceutical Drug Synthesis
The pharmaceutical industry relies heavily on a complex array of chemical intermediates to synthesize life-saving drugs. P-Phenetidine, also known as 4-ethoxyaniline and identified by CAS number 156-43-4, is a crucial building block in this vital sector. Its chemical properties make it indispensable for the production of various active pharmaceutical ingredients (APIs). This article explores the significance of P-Phenetidine in pharmaceutical synthesis and the importance of sourcing it from reliable manufacturers.
Understanding P-Phenetidine in Pharmaceutical Synthesis: P-Phenetidine, a light yellow to reddish-brown transparent liquid, possesses a molecular formula of C8H11NO. Its aniline structure, modified with an ethoxy group, provides specific reactivity that is leveraged in multi-step synthesis of complex drug molecules. Historically, it has been associated with the metabolism of certain analgesics like phenacetin, highlighting its biological relevance. For modern pharmaceutical development, P-Phenetidine serves as a key intermediate, contributing essential structural elements to new chemical entities (NCEs) and established APIs.
Quality Assurance for Pharmaceutical Grade P-Phenetidine: In the pharmaceutical industry, the quality of intermediates directly impacts the safety and efficacy of the final drug product. Therefore, when you buy P-Phenetidine, stringent quality control is paramount. Manufacturers and suppliers must adhere to high purity standards, often exceeding 99%, with meticulous control over impurities, including related compounds and residual solvents. A comprehensive Certificate of Analysis (CoA) from the supplier is non-negotiable, detailing all relevant parameters. As a leading chemical supplier, we ensure our P-Phenetidine meets these exacting pharmaceutical standards.
The Advantage of Sourcing from Trusted Manufacturers: Pharmaceutical companies often seek to buy intermediates in bulk to ensure consistent supply and cost-effectiveness. Partnering with experienced chemical manufacturers based in China, such as ourselves, offers significant advantages. These include direct sourcing, competitive pricing, and adherence to rigorous quality management systems. Our production facilities are equipped to handle large-scale synthesis, ensuring that your supply chain remains robust and uninterrupted.
Technical Considerations and Support: While P-Phenetidine is a critical component, its sensitivity to air and light means that proper handling and storage are essential to maintain its integrity. Consulting the Safety Data Sheet (SDS) provided by the supplier is crucial for safe laboratory and manufacturing practices. Furthermore, understanding the reaction kinetics and optimal conditions for incorporating P-Phenetidine into your specific API synthesis pathways is vital for process efficiency. We offer technical support to assist our clients in maximizing the utility of our products.
Conclusion: P-Phenetidine (CAS 156-43-4) stands as a vital intermediate in the pharmaceutical landscape, enabling the synthesis of critical medications. By selecting a high-purity product from a reliable manufacturer and supplier, pharmaceutical companies can ensure the quality, safety, and efficacy of their final drug formulations. If your company is looking to purchase P-Phenetidine for pharmaceutical applications, engage with our team to secure a consistent supply of this essential chemical.
Perspectives & Insights
Silicon Analyst 88
“Historically, it has been associated with the metabolism of certain analgesics like phenacetin, highlighting its biological relevance.”
Quantum Seeker Pro
“For modern pharmaceutical development, P-Phenetidine serves as a key intermediate, contributing essential structural elements to new chemical entities (NCEs) and established APIs.”
Bio Reader 7
“Quality Assurance for Pharmaceutical Grade P-Phenetidine: In the pharmaceutical industry, the quality of intermediates directly impacts the safety and efficacy of the final drug product.”